Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 08:11 am Purchase |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 3,761,439 6.060% |
1,396,132 (+59.03%) |
Filing History |
| 2022-02-09 1:02 pm Sale |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
STATE STREET CORP STT |
1,046,377 1.690% |
-1,476,167 (-58.52%) |
Filing History |
| 2022-01-12 2:15 pm Purchase |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 4,468,835 7.100% |
1,789,000 (+66.76%) |
Filing History |
| 2022-01-10 12:54 pm Purchase |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BLACKROCK INC BLK |
2,241,217 3.600% |
177,012 (+8.58%) |
Filing History |
| 2022-01-04 9:16 pm Sale |
2021-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
SABBY MANAGEMENT LLC | 3,095,410 11.000% |
-2,618,876 (-45.83%) |
Filing History |
| 2021-12-10 12:18 pm Purchase |
2021-12-02 | 13G | Esperion Therapeutics, Inc. ESPR |
CVI Investments, Inc. | 6,274,385 9.900% |
6,274,385 (New Position) |
Filing History |
| 2021-12-09 4:54 pm Purchase |
2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
Deep Track Capital, LP | 6,345,790 9.990% |
6,345,790 (New Position) |
Filing History |
| 2021-12-09 10:11 am Purchase |
2021-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
SABBY MANAGEMENT LLC | 5,714,286 11.000% |
5,714,286 (New Position) |
Filing History |
| 2021-12-07 5:19 pm Purchase |
2021-12-07 | 13G | Esperion Therapeutics, Inc. ESPR |
Flynn James E | 10,000,000 8.170% |
10,000,000 (New Position) |
Filing History |
| 2021-05-28 5:00 pm Purchase |
2021-05-19 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 4,477,964 15.900% |
530,000 (+13.42%) |
Filing History |
| 2021-02-16 4:42 pm Sale |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Pentwater Capital Management LP | 722,580 2.590% |
-1,545,681 (-68.14%) |
Filing History |
| 2021-02-16 09:56 am Sale |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
MARSHALL WACE LLP | 1,370,352 4.900% |
-157,749 (-10.32%) |
Filing History |
| 2021-02-12 4:58 pm Purchase |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BB BIOTECH AG | 3,947,964 14.200% |
220,000 (+5.90%) |
Filing History |
| 2021-02-11 7:45 pm Unchanged |
2021-02-11 | 13G | Esperion Therapeutics, Inc. ESPR |
PLATINUM ASSET MANAGEMENT LTD | 0 0.000% |
0 (Unchanged) |
Filing |
| 2021-02-11 1:03 pm Purchase |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
STATE STREET CORP STT |
2,522,544 9.050% |
1,421,035 (+129.01%) |
Filing History |
| 2021-02-10 10:52 am Sale |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
The Vanguard Group | 2,365,307 8.480% |
-282,604 (-10.67%) |
Filing History |
| 2021-02-09 2:56 pm Purchase |
2021-02-09 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 3,998,010 14.300% |
161,567 (+4.21%) |
Filing History |
| 2021-02-05 07:51 am Sale |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
BLACKROCK INC BLK |
2,064,205 7.400% |
-4,027 (-0.19%) |
Filing History |
| 2021-01-06 2:37 pm Unchanged |
2020-12-31 | 13G | Esperion Therapeutics, Inc. ESPR |
Meditor Group Ltd | 2,679,835 9.600% |
0 (Unchanged) |
Filing History |
| 2020-12-03 2:36 pm Purchase |
2020-12-03 | 13G | Esperion Therapeutics, Inc. ESPR |
WASATCH ADVISORS INC | 3,836,443 13.800% |
3,836,443 (New Position) |
Filing History |